DORIAN MANN: Open Payments
NPI 1821440215 · BLACKSBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,670 in 151 payments from 37 companies in 2025. Trend: 2023 $1,287 · 2024 $2,600 · 2025 $2,670
Food & beverage: $2,495Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $450 |
| Amgen Inc. | 13 | $309 |
| AstraZeneca Pharmaceuticals LP | 6 | $290 |
| PFIZER INC. | 13 | $197 |
| Novo Nordisk Inc | 14 | $147 |
| Neurocrine BioSciences, Inc. | 10 | $142 |
| Verona Pharma, Inc. | 8 | $136 |
| Astellas Pharma US Inc | 5 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $79 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
Products named: PROLIA, UBRELVY, AIRSUPRA, NURTEC ODT, INGREZZA, FARXIGA, Ohtuvayre, Veozah.
Industry payments across SC — which companies pay providers there.
